# Saizen® E-Device User Trial

> **NCT00450190** · PHASE3 · COMPLETED · sponsor: **Merck KGaA, Darmstadt, Germany** · enrollment: 20 (actual)

## Conditions studied

- Growth Disorders

## Interventions

- **DEVICE:** Saizen® E-Device

## Key facts

- **NCT ID:** NCT00450190
- **Lead sponsor:** Merck KGaA, Darmstadt, Germany
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-02-28
- **Primary completion:** 2006-09-30
- **Final completion:** 2006-09-30
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2018-07-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00450190

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00450190, "Saizen® E-Device User Trial". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00450190. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*